Martine A Rothblatt
Director; Director, Chairperson & CEO · 165 filings · Latest: Oct 15, 2026
BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Sep 3, 2026 | Sale | $487.54 | 9,500 | $4.6M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Sep 3, 2026 | Option Exercise | $134.32 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Sep 2, 2026 | Sale | $493.46 | 9,500 | $4.7M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Sep 2, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Sep 1, 2026 | Sale | $514.09 | 9,500 | $4.9M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Sep 1, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | MARTINE ROTHBLATT | — | Sep 1, 2026 | Proposed Sale | $510.38 | 199,500 | $101.8M | — | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 31, 2026 | Sale | $511.09 | 9,500 | $4.9M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 31, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 28, 2026 | Sale | $517.51 | 9,500 | $4.9M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 28, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 27, 2026 | Sale | $522.57 | 9,500 | $5.0M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 27, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 26, 2026 | Sale | $517.28 | 9,500 | $4.9M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 26, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 25, 2026 | Sale | $517.71 | 9,500 | $4.9M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 25, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 24, 2026 | Sale | $511.97 | 9,500 | $4.9M | 324,443 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 24, 2026 | Option Exercise | $135.42 | 9,500 | $1.3M | 333,943 | |
UTHR | Martine A Rothblatt | Director, Chairperson & CEO | Aug 21, 2026 | Sale | $518.39 | 9,500 | $4.9M | 324,443 |